Pharmeco Group

Russian pharmaceutical, biologics and consumer healthcare group. Established in 2001 Sales: more than USD 500 M Employed: more than 1100 people The Group operates in 4 main areas: 1) Research & Development (Biomaterials and biotechnology, aptamers, Nano-platforms); 2) Drugs Manufacturing (Fill & Finish, Primary & secondary packaging); 3) Market access, Sales & Distribution (Hospital/specialty care, Pharmacies, Medical equipment & laboratory diagnostics); 4) Construction & Equipping (Construction and equipping of social infrastructure facilities (institutions, hospitals & clinics). Group's main advantages: - Technology transfer, localization of foreign manufacturing on the territory of Russia - Focus on hospital and reimbursement segment - Five (5) GMP compliant manufacturing sites (Moscow, Ryazan, Podolsk, Novosibirsk) - Warehouses with efficient logistics and distribution in compliance with GDP/GSP - R&D of local drugs, including with cooperation with international companies and universities - Long-term experience in the field of launch and sales of innovative products